Clinical implications of trials investigating drug-drug interactions between cannabidiol and enzyme inducers or inhibitors or common antiseizure drugs

Patsalos, PN; Szaflarski, JP; Gidal, B; VanLandingham, K; Critchley, D; Morrison, G

Patsalos, PN (corresponding author), UCL Queen Sq Inst Neurol, Dept Clin & Expt Epilepsy, London WC1N 3BG, England.

EPILEPSIA, 2020; 61 (9): 1854

Abstract

Highly purified cannabidiol (CBD) has demonstrated efficacy with an acceptable safety profile in patients with Lennox-Gastaut syndrome or Dravet syndr......

Full Text Link